Back to Browse Journals » Journal of Inflammation Research » Volume 3

Inflammatory cytokines and atrial fibrillation: current and prospective views

Authors Hadi AR Hadi, Alawi A Alsheikh-Ali, Wael AL Mahmeed, et al.

Published Date August 2010 Volume 2010:3 Pages 75—97

DOI http://dx.doi.org/10.2147/JIR.S10095

Published 30 August 2010

Hadi AR Hadi, Alawi A Alsheikh-Ali, Wael AL Mahmeed, Jassim M Al Suwaidi

Institute of Cardiac Sciences, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

Abstract: Atrial fibrillation (AF) is the most common sustained arrhythmia and a ­challenging clinical problem encountered in daily clinical practice. There is an increasing body of evidence linking inflammation to a broad spectrum of cardiovascular conditions including AF. Historical evidence supports an association between AF and inflammation and is consistent with the association of AF with inflammatory conditions of the heart, such as myocarditis and pericarditis. AF has been associated with myocardial oxidative stress, and antioxidant agents have demonstrated antiarrhythmic benefit in humans. Increased plasma interleukin (IL)-6, C-reactive protein (CRP), and plasma viscosity support the existence of an inflammatory state among “typical” populations with chronic AF. These indexes of inflammation are related to the prothrombotic state and may be linked to the clinical characteristics of the patients (underlying vascular disease and comorbidities), rather than simply to the presence of AF itself. It has been suggested that inflammation may have a role in the development of atrial arrhythmias after cardiac surgery, and that a genetic predisposition to develop postoperative complications exists. Cytokines can have a prognostic significance; IL-6 levels, CRP, and other cytokines may have prognostic value in AF. Cytokine lowering therapies, statins, angiotensin converting enzyme inhibitors and other anti-inflammatory agents may have a role in the treatment of AF. The present article provides an overview of the evidence linking inflammatory cytokines to AF and their therapeutic and prognostic implications.

Keywords: atrial fibrillation, inflammation, cytokines

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Pleiotropic effects of statins in atrial fibrillation patients: the evidence

Hadi AR Hadi, Wael Al Mahmeed, Jassim Al Suwaidi, Samer Ellahham

Vascular Health and Risk Management 2009, 5:533-551

Published Date: 17 June 2009

Readers of this article also read:

Multifunction hexagonal liquid-crystal containing modified surface TiO2 nanoparticles and terpinen-4-ol for controlled release

Manaia EB, Kaminski RCK, Oliveira AG, Corrêa MA, Chiavacci LA

International Journal of Nanomedicine 2015, 10:811-819

Published Date: 22 January 2015

Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma

Ansari J, Hussain SA, Ansari A, Glaholm J

Biologics: Targets and Therapy 2013, 7:39-46

Published Date: 28 February 2013

Attenuation of niacin-induced prostaglandin D2 generation by omega-3 fatty acids in THP-1 macrophages and Langerhans dendritic cells

VanHorn J, Altenburg JD, Harvey KA, Xu Z, Kovacs RJ, Siddiqui RA

Journal of Inflammation Research 2012, 5:37-50

Published Date: 14 March 2012

Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan–folic acid micelles

Wang F, Chen Y, Zhang D, Zhang Q, Zheng D, Hao L, Liu Y, Duan C, Jia L, Liu G

International Journal of Nanomedicine 2012, 7:325-337

Published Date: 18 January 2012

Career choices among medical students in Bangladesh

SM Moslehuddin Ahmed, Md Anwarul Azim Majumdar, Rezina Karim, et al

Advances in Medical Education and Practice 2011, 2:51-58

Published Date: 14 February 2011

Existence of seven human IL-1R1 promoters

Qiming Li, Hao Zhang, Qun Chen, et al

Journal of Inflammation Research 2010, 3:17-24

Published Date: 25 February 2010

Inflammatory mechanisms in the lung

B Moldoveanu, P Otmishi, P Jani, J Walker, X Sarmiento, et al

Journal of Inflammation Research 2009, 2:1-11

Published Date: 16 December 2008

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension

Douglas J Rhee, James H Peace, Sushanta Mallick, Theresa A Landry, Michael VW Bergamini, and the Study Group*

Clinical Ophthalmology 2008, 2:313-319

Published Date: 30 June 2008

Glucosamine hydrochloride for the treatment of osteoarthritis symptoms

Beth Anne Fox, Mary M Stephens

Clinical Interventions in Aging 2007, 2:599-604

Published Date: 3 January 2007